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Summary 
Aging alone is associated with a wide range of alterations in brain structure and function as well as 
age-associated cognitive decline and pathological neurodegeneration. Years of research have shown 
that brain pathology such as neurofibrillary tangles, amyloid deposition (Aβ), and cerebrovascular 
pathology contribute to decline of cognitive functions in aging and Alzheimer’s Disease (AD). Recent 
research has pointed out that certain lifestyle factors contribute to the ability to cope with pathology, 
known as resilience factors, while in contrast, risk factors can accelerate and increase the vulnerability 
towards cognitive decline and neurodegeneration.  
 
This work explores risk and resilience factors across a diverse spectrum of participants ranging from 
cognitively intact older adults, to mild cognitive impairment (MCI), and clinical AD with a holistic 
integration of behavioral measures and multimodal neuroimaging markers. Based on four studies this 
dissertation investigates the association of AD and cerebrovascular pathology, functional connectivity 
networks and cognition in a pooled data set of 645 individuals. Study 1 shows the characterization of 
cognitive performance across cognitively intact elders and the specific influence of demographic 
factors such as age, sex, and education on cognition. Using a multimodal approach, Study 2 
disentangles the relationship between amyloid deposition (Aβ) and functional connectivity across the 
AD spectrum at a global and local level. We found a global positive correspondence and a local 
detrimental effect of Aβ on connectivity centers, starting at the preclinical phase. Study 3 focuses on 
the resilience role of functional connectivity in the face of cerebrovascular pathology. Results 
demonstrate the mitigating effect of functional connectivity on the impact of white matter lesions on 
cognition. Finally, Study 4 investigates the neurobiological underpinnings of psychological risk in 
healthy and at-AD-risk individuals. We show that the presence of subjective cognitive decline is 
associated with increased psychological risk, which itself was linked to aberrant functional 
connectivity in AD target regions and beyond.  
 
In summary, our results shed light on the diverse mechanistic underpinning of functional brain 
networks, hinting at the complex interplay between the brain’s functionality at-rest and the multiple 
pathological processes. Overall, these findings extend the literature on the resilience and risk factors 
in the context of healthy aging and AD, while providing a holistic integration of the complex 
mechanisms at play during the aging process.  
Keywords:  
Risk, Resilience, Aging, Alzheimer’s disease, neuroimaging  
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Zusammenfassung 
Der Alterungsprozess ist mit einem breiten Spektrum von Veränderungen der Gehirnstruktur und -
funktion, sowie altersbedingter kognitiver Verschlechterung und pathologischer Neurodegeneration 
verbunden. Jahrelange Forschungen haben gezeigt, dass Pathologien wie neurofibrilläre Bündel, 
Amyloid Ablagerungen (Aβ) und zerebrovaskuläre Störungen zur Abnahme der kognitiven 
Leistungsfähigkeit im Alter und bei der Alzheimer Demenz (AD) beitragen. Jüngste 
Forschungsergebnisse deuten darauf hin, dass bestimmte Lebensstilfaktoren die Fähigkeit, mit 
Pathologien umzugehen, fördern. Hierbei handelt es sich um die sogenannten Resilienzfaktoren. Im 
Gegensatz dazu stehen die Risikofaktoren, welche die Vulnerabilität für kognitive Verschlechterung 
und Neurodegeneration erhöhen und diese Prozesse beschleunigen können. 
Diese Arbeit exploriert Risiko- und Resilienzfaktoren in einem breiten Spektrum von Probanden, von 
kognitiv normalen älteren Menschen über Personen mit leichter kognitiver Beeinträchtigung bis hin 
zu Personen mit klinischer AD mittels einer holistischen Integration behavioraler Messungen und 
Markern multimodaler Neurobildgebung. Basierend auf vier Studien untersucht diese Dissertation die 
Assoziation von AD und zerebrovaskulärer Störungen, funktioneller Konnektivitätsnetzwerke und 
Kognition in einem gepoolten Datensatz bestehend aus 645 Individuen. Studie 1 dient der 
Charakterisierung der kognitiven Leistungsfähigkeit bei kognitiv intakten älteren Menschen und des 
spezifischen Einflusses von demografischen Faktoren wie Alter, Geschlecht und Bildung auf die 
Kognition. Mithilfe eines multimodalen Ansatzes entwirrt Studie 2 die Beziehung zwischen Aβ und 
funktioneller Konnektivität über das AD Spektrum auf einem globalen und lokalen Level. Es liefert 
Evidenz dafür, dass das Fortschreiten der Amyloid Ablagerungen entlang funktioneller 
Konnektivitätsnetzwerke in präklinischen Stadien beginnt. Studie 3 konzentriert sich auf die resiliente 
Rolle funktioneller Konnektivität bei Vorhandensein zerebrovaskulärer Pathologien. Ein 
abschwächender Effekt der funktionellen Konnektivität auf den Einfluss von Läsionen der weißen 
Substanz auf die Kognition konnte gezeigt werden. Abschließend untersucht Studie 4 die 
neurobiologischen Grundlagen des psychologischen Risikos gesunder Personen und Personen mit 
erhöhtem Risiko für AD. Das Vorhandensein subjektiver kognitiver Verschlechterungen ist mit einem 
erhöhten psychologischen Risiko assoziiert, welches mit aberranter funktioneller Konnektivität in 
AD-relevanten Regionen im Zusammenhang steht.  
Zusammenfassend erweitern die Ergebnisse der vorliegenden Dissertation die Literatur zu Resilienz- 
und Risikofaktoren im Kontext gesunden Alterns und AD, indem sie eine holistische Integration der 
komplexen Mechanismen während des Alterungsprozesses liefert.  
Resilienz- Risikofaktoren, Alterungsprozess, Alzheimer Demenz, Bildgebung 
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1 Theoretical Background 
1.1 Introduction 
 “The aging brain: the mind is resilient, it's the body that fails.”1  
People around the world are living longer, but many are also less healthy lives for longer 
(Murray et al., 2015). Understanding the science of healthy aging has never been more imperative. 
Aging alone is associated with a wide range of alterations in brain structure and function, as well as 
age-associated cognitive decline—all of which contribute to the fact that age is one of the strongest 
risk factors for neurodegenerative disorders (Hedden & Gabrieli, 2004; Yankner, Lu, & Loerch, 
2008). Alzheimer’s Disease (AD), the most common form of dementia, is considered an “impeding 
epidemic” due to the rapidly aging global population and increasing life expectancy rates. By 2050, it 
is estimated that over 135 million individuals will suffer from dementia if no effective therapies are 
found (Alzheimer’s Disease International, 2015). Thus, not only is it crucial to understand the 
neurophysiological mechanisms and determinants of brain and cognitive health, but also there is a 
converging need for a holistic integration of the mechanisms at play in order to understand, treat, and 
prevent pathological aging.  
Recent advances in functional and molecular neuroimaging have facilitated the possibility of 
tracking brain alteration in structure and function as well as measuring in vivo pathology. Studies 
have shown that neurofibrillary tangles, amyloid beta (Aβ) deposition, cerebrovascular pathology and 
neurodegeneration contribute to decline of cognitive functions in aging and AD (Blennow & 
Zetterberg, 2018; Knopman et al., 2003; Raz & Rodrigue, 2006; Wirth et al., 2013; Yankner et al., 
2008). Over the last two decades, the contribution of the neuroimaging field has been of paramount 
importance and has allowed for two crucial lines of research in aging and AD. First, the development 
of neuroimaging biomarkers has facilitated the concept of AD as a “continuum,” which has lead to the 
study of an essential preclinical phase of the disease (Jack et al., 2018; Sperling et al., 2011). And 
second, the presence of increased pathology in cognitively intact older individuals has brought about 
                                                          
1 Taken from: http://www.nytimes.com/1991/04/16/science/the-aging-brain-the-mind-is-resilient-it-s-the-body-that-
fails.html?pagewanted=all 
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the study of the impact of modifiable lifestyle factors, both resilience (i.e. protective) and risk (i.e. 
aversive) factors, on age- and disease-related cognitive decline (Baumgart et al., 2015; Jansen et al., 
2015). Converging these two lines of research, this works explores risk and resilience mechanisms 
using a multimodal neuroimaging integration with behavioral measures, while advancing the 
understanding of the intricate brain mechanisms during aging and AD.  
The following sections will provide a theoretical background for the presentation of the 
research I have conducted. This will be followed by a consolidation of the aims and research 
questions this dissertation answers along with a brief outline of the studies included. Finally, the 
overall results are discussed along considering limitations and future research directions.  
1.2 General background: Alzheimer’s disease continuum 
Alzheimer’s disease is a neurodegenerative disease characterized by the presence of Aβ 
aggregations and neurofibrillary tangles (tau) accompanied by neurodegeneration and a gradual and 
continued pattern of cognitive and functional impairment (Blennow, Leon, & Zetterberg, 2006; 
Blennow & Zetterberg, 2018). Advances in functional and molecular neuroimaging, which allow in 
vivo measuring of neuropathology and brain changes, have contributed to the development of 
established neuroimaging biomarkers (Jack et al., 2018). Evidence from longitudinal studies, genetic-
at-risk cohorts, and cognitively intact older individuals suggest that neuropathological changes begin 
decades before the onset of detectable clinical symptoms (Sperling et al., 2011). This scientific 
progress has led to the representation of the disease in form of a “continuum”.  
In 2011, established guidelines were presented to include three stages of the AD: (1) 
presymptomatic or preclinical Alzheimer’s, (2) mild cognitive impairment due to Alzheimer’s (MCI), 
and (3) dementia due to AD (Sperling et al., 2011). The physiopathological cascade of AD 
encompasses the time between the initial brain changes of AD in a preclinical phase, leading to the 
prodromal stage of MCI followed by the full symptoms of advanced AD. As advancements in 
imaging and chemical biomarkers proceeded, guidelines were recently revisited in 2018 for a further 
refinement of the biological basis of the disease continuum. A research framework was provided to 
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guide work on biomarkers based on the “Aβ deposition, pathologic Tau and Neurodegeneration 
[AT(N)]” classification system (Jack et al., 2018). Briefly, the following stages of the continuum 
(Figure 1) are stated for clarity of this work: 
 
Figure 1. Illustration of the AD continuum from cognitively intact individuals to AD dementia with degree of 
cognitive deficits and pathology. Image from (Chételat, 2018) 
 
The presymptomatic or preclinical stage of AD (Figure 1) is defined as individuals who have 
no cognitive or behavioral symptoms, but have evidence of the early brain changes of Alzheimer’s (as 
detected by brain imaging or a bio-marker tests such as Aβ load) (Sperling et al., 2011). Most 
recently, the field has also progressed towards the earliest stages of the disease to include individuals 
with subjective cognitive decline (SCD). These individuals have persistent self-experienced cognitive 
decline in the absence of objective cognitive impairments as measured by normed-standardized 
cognitive tests (Jessen et al., 2014).  
Mild cognitive impairment due to Alzheimer’s (MCI) is the stage where mild changes in 
memory and thinking are noticeable, where cognitive decline is greater than expected for an 
individuals’ age and education level—but not severe enough to impact daily function—along with 
evidence of AD biomarkers (Albert et al., 2011).  
Dementia due to AD is characterized by noticeable memory, thinking, and behavioral 
symptoms, as well as disruption of daily functions. Criteria diagnosis includes a gradual onset and 
continuing decline of impairments in social and occupational function in the absence of other 
psychiatric, neurological or systemic disease causing cognitive deficits (McKhann et al., 2011; 
Spillantini & Goedert, 2013). It refers to Aβ plaque and pathological tau aggregates, defined in vivo 
or post-mortem by abnormal biomarkers of Aβ and pathological tau.  
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1.3 Pathophysiological mechanisms and neuroimaging markers  
Despite the major advances in our understanding of AD, the pathophysiological mechanisms of 
the disease are not yet clear. There are several competing hypotheses concerning the interaction, 
stages and causes of the pathological hallmarks of AD with the “amyloid cascade” and “tau 
hypothesis” still up for debate. Both hypotheses assign a pivotal causal role to the respective pattern of 
disease pathogenesis. Most current evidence supports the amyloid hypothesis, which proposes that Aβ 
accumulates (first) and causes the cascade of negative effects such as tau formation, 
neurodegeneration, cell loss, vascular damage, cognitive decline, ultimately leading to the clinical 
onset of Alzheimer’s Disease (Hardy & Selkoe, 2002; Jack et al., 2018). However, this position is 
challenged by evidence for tau-related neuronal injury independent of Aβ (Knopman et al., 2013; 
Spillantini & Goedert, 2013). In parallel, recent neuroimaging studies haven taken into consideration 
the normal structure and function of the brain to provide evidence for the so-called network 
degeneration hypothesis suggesting that neurodegeneration spreads along brain networks (inter-
connected brain regions) which are functionally connected rather than spatially neighboring areas 
(Jones et al., 2016; Seeley, Crawford, Zhou, Miller, & Greicius, 2009; Zhou, Gennatas, Kramer, 
Miller, & Seeley, 2012) 
Over and above the serial models of causality, the development of multimodal neuroimaging 
techniques has advanced the understanding of pathology and brain mechanisms that happen in 
parallel. This allows an understanding of the complimentary and complex brain relationships at play 
during normal and pathological aging. It is important to note that this work does not involve itself 
with the causative pathophysiological order of brain changes in cognitive decline and AD. However, 
for the purpose of simplicity, it accepts a general model of pathology, neuronal degeneration, and 
cognitive decline outlined in Figure 2, some of which may happen in parallel. The following section 
will provide a brief overview of the clinical neuroimaging techniques used (illustrated in Figure 2) 
and their respective measures along with the relevant findings in aging and AD.  
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Figure 2. Simplified model of the AD pathogenesis and illustration of neuroimaging biomarkers available for 
multi-modal integration of the underlying neurobiological processes. Adapted from (Sorg & Grothe, 2015; 
Villeneuve, Wirth, & La Joie, 2015) Key: CSF: cerebrospinal fluid, PET: positron emission tomography, Aβ: 
amyloid beta, WML: white matter lesions MRI: magnetic resonance imaging, fMRI: functional magnetic 
resonance imaging GM: gray matter  
1.3.1 Amyloid pathology: Position-emission tomography (PET) 
The accumulation of the Aβ protein in the brain is a key hallmark characteristic of AD, 
commonly known as “plaques”. The Aβ plaques follow a specific temporal-pattern with initial 
depositions or accumulation observed in basal portions of the isocortex decades before the onset of 
symptoms (Braak & Braak, 1991; Jansen et al., 2015). Previously only measurable through 
cerebrospinal fluid (CSF), advancements in molecular imaging techniques have now allowed for the 
reliable in vivo imaging of Aβ pathology with positron-emission tomography (PET). The labeling of 
Aβ pathology in the human brain is preformed using several tracers, the most common of which are 
Pittsburgh Compound-B (PIB) and Florbetapir (AV-45). Brain regions with high levels of amyloid 
deposition include lateral and medial parietal areas such as the posterior cingulate cortex, precuneus 
as well as frontal and temporal brain regions (Grothe & Teipel, 2016). Amyloidosis—the presence of 
brain Aβ —is consistently reported in almost all subjects with clinical AD, in 50% of subjects with 
MCI and in 20-30% of cognitively intact older individuals (Blennow et al., 2006; Jansen et al., 2015; 
Sperling et al., 2011). Paradoxically, individuals with a clinical phenotype of MCI and AD have also 
reported negative amyloid PET (Doraiswamy et al., 2012; Petersen et al., 2013). These findings 
  
15 
suggest that amyloid-β pathology may be necessary, but not sufficient in isolation, to predict AD 
trajectory  
1.3.2 Atrophy and Lesions: Structural magnetic resonance imaging (MRI) 
The MRI is an imaging technique which allows the visualization of detailed internal structures 
in the human body. In the human brain it can be used to visual gray and white matter, and has been 
extensively used to explore the atrophy patterns related to normal and pathologic aging (Ibrahim & 
Osman, 2010). Atrophy can be quantified by estimating changes in cortical thickness and volume via 
automatic and manual segmentation (Busatto, Diniz, & Zanetti, 2008; Malone et al., 2015). Voxel-
based morphometry is an additional technique used to estimate white and grey matter density at a 
voxel level, as a measure of integrity and atrophy. Typical regions involving first atrophy changes in 
AD include the hippocampus and entorhinal cortex in the medial temporal lobe (MTL), and the 
precuneus and posterior cingulate cortex (PCC) in the medial parietal cortex (Buckner et al., 2005).  
 Volumetric studies suggest an overall shrinkage and thinning of the cortex associated with 
increased age (Raz & Rodrigue, 2006; Walhovd et al., 2011). In addition to volume changes, 
pathology in white matter, referred to as “lesions”, is assessed with a special sequence of MRI, 
namely fluid-attenuated inversion recovery (FLAIR) images. White matter lesions (WML) are 
considered part of cerebrovascular pathology along with microbleeds and larcunar infarcts. Those 
WML are common in more than 50 % of the elderly population (Prins & Scheltens, 2015). Increased 
WML load is associated with worse cognitive performance, and known to affect brain structure (Raz 
& Rodrigue, 2006). In general, changes structural integrity in both gray and white are consistently 
reported in both healthy and pathological aging (Jack et al., 2009; Raz & Rodrigue, 2006; Walhovd et 
al., 2011).  
1.3.3 Functional Connectivity: Resting-state functional magnetic resonance (fMRI) 
Brain activity can be measured with Functional Magnetic Resonance Imaging (fMRI) via the 
blood-oxygenation-level-dependent (BOLD) signal (Friston, 1994; Huettel, Song, & McCarthy, 
2004). The fMRI technique allows the recording of spontaneous brain activity fluctuations while the 
individual lie at rest or performing a task in the scanner (Biswal, Zerrin Yetkin, Haughton, & Hyde, 
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1995). The BOLD signal is essentially reflecting a hemodynamic response, namely the fast transport 
of glucose and oxygen from cerebral blood to brain tissue in order to support neurotransmitter activity 
and sustain controlled firing (Huettel, Song, & McCarthy, 2004). Animal electrophysiological 
recordings provide evidence that local field potentials best predict fMRI responses, indicating that the 
BOLD signal primarily measures the processing of neuronal information within a brain 
region(Logothetis, Pauls, Augath, Trinath, & Oeltermann, 2001).  
In resting-state fMRI methodology, when the brain is at rest, intrinsic brain activity is detected 
by measuring ongoing fluctuations of the BOLD signal at a slow frequency of about 0.1 Hz (Van Dijk 
et al., 2010). Synchronized intrinsic BOLD activity of distant brain regions has been used to derived 
patterns of functional connectivity (i.e. temporal correlations in fMRI data) denominated brain 
resting-state networks (RNs) (Allen et al., 2011; Smith et al., 2009). Several RNs have been 
established for different critical functions such as sensorimotor, frontal-parietal, salience, default 
mode processing(Allen et al., 2011; Fox et al., 2005; Menon & Uddin, 2010). Some of these networks 
resemble activation maps from task-fMRI studies suggesting that RNs underpin human brain function 
(Allen et al., 2011).  
Resting-state networks  
Certain networks, such as the default mode network (DMN), are especially relevant for AD 
(Buckner, Andrews-Hanna, & Schacter, 2008; Greicius, Srivastava, Reiss, & Menon, 2004; Sperling 
et al., 2009). In general, the DMN is associated with mental states such as mnemonic processes, 
planning, and self-referential thinking (Buckner et al., 2008). It is a network known to show first AD 
related changes (Jones et al., 2015; Sorg et al., 2007; Zhang et al., 2010). Alterations in the DMN are 
related to cognitive decline and decreases in network connectivity is also seen with higher degree of 
clinical impairment from MCI to AD (Damoiseaux, Prater, Miller, & Greicius, 2012; Koch et al., 
2015).  
The Fronto-parietal network (aka. Central Executive) is considered a cognitive control network 
important for the flexible regulation of activity to other functional networks (Cole, Repovs, & 
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Anticevic, 2014; Cole, Yarkoni, Repovs, Anticevic, & Braver, 2012). Components of this networks 
include the lateral prefrontal cortex (LPFC), whose brainwide influence is considered to support 
processes central to human intelligence ( Cole, Yarkoni, Repovs, Anticevic, & Braver, 2012). Also 
considered a control network is the Salience Network, a brain network anchored in the anterior 
cingulate cortex (ACC) and anterior insula (Menon, 2015). It is a complex network involved in the 
integration of input from sensory, emotion and cognitive information (Menon & Uddin, 2010); and 
considered a dynamic mediator, switching between the DMN and the fronto-parietal network(Bressler 
& Menon, 2010).  
In general, functional connectivity can be studied in different ways: for example, integrity of 
the networks, the relationships between connectivity and behavior, the analysis of the coherent 
increase or decrease of connectivity, interconnectivity between network etc. Altogether, these 
approaches help form the understanding of brain functioning in healthy and pathological aging.  
 
Box 1. Summary Key Findings 
 Aβ pathology is a key hallmark of AD related to neurodegeneration and impairment. 
 Increase gray matter atrophy is present in normal and pathology aging. 
 Decrease of white matter integrity and increase WML load are associated with detrimental 
effects. 
 DMN is a prominent AD relevant network, showing differential connectivity patterns across 
the Disease Continuum. 
 The Fronto-parietal and the Salience network are cognitive control networks important for 
regulation and healthy brain functioning.  
 
1.4 Resilience  
The amount of pathology and atrophy, for the most part, is concurrent with the clinical 
manifestation of the disease and degree of decline (Knopman et al., 2003; Mormino et al., 2014; 
Yankner et al., 2008). However, since the first observations of the disconnect between the degree of 
pathology and cognitive decline, there has been a lot of interest in understanding the mechanisms 
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underlying this resilience(Crystal et al., 1988; Morris et al., 1996; Stern, 2002). Several concepts have 
been appointed to the study of what makes individuals robust against aging or disease related 
pathologies; these include cognitive reserve (CR), brain reserve, brain maintenance, and more general 
notions such as lifestyle factors, compensation and neuroprotection (Arenaza-Urquijo & Vemuri, 
2018; Arenaza-Urquijo, Wirth, & Chételat, 2015; Cabeza et al., 2018; Stern, 2012). These concepts all 
refer to the hypothetical capacity of the brain (i.e. adaptability, efficiency) of maintaining function in 
the face of aging, pathology or insult, known to many originally as the CR hypothesis (Stern et al., 
2018).  
Box. 2 Key Concepts 
 Reserve/Resilience: “Heuristic concept that helps explain the individual differences in 
cognition, function, or clinical status, relative to aging and brain disease.” Stern et al., 2018 
 
 There is no direct measurement of reserve, however several lifestyle factors have been used as 
proxies 
 
Existent evidence highlights that certain lifestyle factors help maintain and protect function as 
well as delay the effects of pathology. For example, it has been repeatedly shown that educational 
attainment (Brickman et al., 2011; Stern, Albert, Tang, & Tsai, 1999; Vemuri et al., 2012; Wilson et 
al., 2004), physical activity (Arenaza-Urquijo et al., 2016; Head et al., 2012; Scarmeas et al., 2003) , 
cognitive enrichment (Scarmeas, Levy, Tang, Manly, & Stern, 2001; Vemuri et al., 2012; Wirth, 
Haase, Villeneuve, Vogel, & Jagust, 2014) are protective lifestyle factors that attenuate the 
detrimental effects of AD and cerebrovascular pathologies. New evidence also expands such 
protective effects to mental practices such as meditation (Chételat et al., 2017), along with 
consideration of the influence of certain psychological factors on the classic reserve mechanisms 
(Bartrés-Faz, Cattaneo, Solana, Tormos, & Pascual-Leone, 2018). Neuroimaging studies have also 
extended the concept of CR to the level of functional brain mechanisms suggesting that those 
individuals with high reserve, have brain activation patterns that reflect higher neural efficiency and 
are thus better able to cope with pathology (Bartrés-Faz & Arenaza-Urquijo, 2011; Barulli & Stern, 
2013). However, the neurobiological mechanisms of this resilience remain to be clearly defined.  
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 In general, a recent integration of all the findings in the resilience factors research field 
proposes a more holistic understanding of the moderating role of lifestyle factors between pathology 
and cognition, see Figure 3. In the context of AD, lifestyle factors may act both through 
neuroprotective and compensatory mechanisms, depending on the pathological stage. For example, 
lifestyle factors may offer a direct neuroprotective effect on pathology in the healthy elderly; while a 
compensatory (moderating) role takes place once pathology has reached a certain level (Arenaza-
Urquijo et al., 2015; Chételat, 2018)  
 
Figure 3. Schematic illustration of the differential expression of resilient mechanisms (neuroprotection and 
compensation) from cognitively healthy elderly to AD dementia, as presented by (Chételat, 2018).  
1.5 Risk factors  
The resilience heuristic conceptually allows for the absence or decrease of a protective factor to 
be referred to as risk factors. The term “risk” is used epidemiologically to describe the future 
probability of disease as a function of a particular exposure. Non-modifiable risk factors (i.e. genetic 
background and age) and modifiable lifestyle risk factors (i.e. dietary and psychological factors) have 
been studied in relation to cognitive impairment and dementia in late life (Hughes & Ganguli, 2009). 
It is now broadly accepted that cognitive impairment and dementia are associated with both genetic 
and environmental factors, and their influence on AD pathophysiological mechanisms are included in 
newer models of the disease (Chételat, 2018; Jack et al., 2018). The most established genetic risk 
marker for AD is the apolipoprotein E 4 (APOE4) gene (Raber, Huang, & Ashford, 2004). Although 
the genetic impact is important to consider, these interactions are beyond the scope of this work.  
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 In the absence of effective treatments for AD and the non-modifiable nature of genes, there is 
considerable interest in the impact of environmental or lifestyle risk factors on cognitive decline in 
healthy and pathological aging. The list of risk factors is extensive and far-reaching as it may begin as 
early as in utero, include environmental factors such as head trauma, and health-related behavior 
(diet/nutrition, tobacco use, etc.) among many others. For an extensive review of all risk factors in 
late-life cognitive impairment and dementia please refer to Hughes & Ganguli, 2009. In the context of 
this work, we will focus on the impact of two risk factors, educational attainment and psychological 
factors.  
Educational attainment is the most researched early-life risk factor for cognitive impairment 
and dementia. Accumulating evidence across cohorts and cultures, suggest that lower educational 
attainment is consistently found to increase risk of cognitive impairment and dementia(Lopez et al., 
2003; Stern et al., 1999; Vemuri et al., 2016; Zhang et al., 1990). The exact mechanisms by which 
education is related to cognitive impairment is not clearly defined, with several explanations which 
include: (1) education as a proxy of socio-economic status, which influences other general life health-
choices; or (2) its neurobiological basis of increasing long-term neuroprotection through long-term 
potentiation (Addae, Youssef, & Stone, 2003) among others. As mentioned earlier in the resilience 
section, educational attainment, along with occupation, premorbid intelligence quotient (IQ), and 
intellectual engagement are all proxies used in the study of CR and resilient mechanisms (Stern et al., 
2018).  
Psychological factors have received less attention, but have been consistently associated with 
increased risk of cognitive decline, MCI risk and dementia (Diniz, Butters, Albert, Dew, & Reynolds, 
2013; Hill et al., 2016a; Lopez et al., 2003). Depressive symptomatology, anxiety, stress coping 
strategies, attitudes towards life and personality are all factors that have the potential to have a 
detrimental effect on healthy aging (Bierman, Comijs, Jonker, & Beekman, 2007; Escher, 
Sannemann, & Jessen, 2019; Johansson et al., 2014; Wilson et al., 2006). The concept of “cognitive 
debt” was recently proposed, as an antonym model of cognitive reserve. According to this concept, 
psychological factors such as anxiety, depression, repetitive negative thinking, sleep disturbance, are 
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all factors that deplete resilience against brain disease and may accelerate cognitive decline in aging 
individuals (Marchant & Howard, 2015).  
Evidence on each of these factors supports the association between negative affect and risk 
for cognitive decline. For example, two major systematic meta-analysis found convincing evidence 
that history of depression and negative affect significantly increases risk of AD (Diniz et al., 2013; 
Ownby, Crocco, Acevedo, John, & Loewenstein, 2006). Anxiety symptoms are suggested to have an 
association with cognitive impairment, risk for dementia and higher conversion rate from MCI to AD 
(Bierman et al., 2007; Sinoff & Werner, 2003; Yochim, Mueller, & Segal, 2013). Likewise, certain 
personality factors, such as neuroticism, have been linked to increased risk of AD and stepper 
cognitive decline rates (Pearman, 2004; Snitz et al., 2015). Recent research has started to focus on the 
neurobiological basis of this risk through the investigation of functional brain changes related to 
affective factors (Fredericks et al., 2018; Munro et al., 2015; Snitz et al., 2015). In sum, evidence 
supports the notion of examining psychological factors and their interactions with neuropathological 
changes across the course of cognitive decline. 
 
  
Figure 4. General overview of some of the factors that contribute to resilience and risk in in the context of 
cognitive decline and AD.  
 
In summary, healthy and pathological aging are accompanied by a complex interaction of 
neurophysiological mechanism within different brain processes and lifestyle factors, which may 
increase or reduce the risk of cognitive decline. The previous theoretical overview section has shown 
the general steps forward in the identification of physiopathological mechanisms across the AD 
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continuum and the determinants of brain health in aging. There is, however, still a need for further 
multimodal studies, which help elucidate the links between risk and resilience factors and their effect 
on brain mechanisms and cognition. Healthy and pathological aging are accompanied by a complex 
interaction of neurophysiological mechanism within different brain processes and lifestyle factors, 
which may increase or reduce the risk of cognitive decline.  
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2 Experimental Aims and Research Questions 
This doctoral dissertation seeks to (1) advance the holistic understanding of brain biomarkers 
(Aβ, functional connectivity, WML) across the AD continuum, (2) further characterizing the 
neurobiological signature of certain risk and resilience factors and their effect on cognition. The aims 
of this research project are divided in several objectives pursued through four different studies.  
1. In the first study, we started at the most basic level assessing cognitive performance in 
cognitively intact elders in a sample of Spanish speakers living in the United States. 
This work was motivated by the lack of descriptive cognitive performance of this 
sample. At the behavioral level, I examined first hand, how does age, sex, and 
education affect cognitive performance in a well-characterized cohort of elders. 
Through this framework, I investigated the effects of modifiable (i.e. years of 
education) and non-modifiable risk factors (i.e. age) on specific neuropsychological 
assessments.  
2. In the second study, we implemented multimodal neuroimaging markers in order to 
investigate the intricate relationship between brain Aβ burden and functional 
connectivity. At the level of underlying brain mechanisms, we wanted to know what is 
the relationship between amyloid deposition and resting-state functional 
connectivity across the AD continuum? We investigated these relationships at a 
global and local level in the DMN in order to elucidate further evidence for the network 
degeneration hypothesis.  
3. Given that brain pathology and functional connectivity interact differently and lifestyle 
factors play a role in these relationships, we wanted to investigate these concepts in the 
context of cerebrovascular pathology. In our third study, we were interested in 
neurobiological basis of these resilience mechanisms in resting-state network. 
Furthermore, we wanted to know if functional connectivity plays a moderating 
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role in attenuating the detrimental effect of cerebrovascular pathology on 
cognition in healthy older adults and individuals with MCI.  
4. Lastly, we were interested in investigating psychological risk at the level of functional 
resting-state networks. In the context of SCD, the earliest stage of the continuum, we 
wanted to further characterize the affective profile that might posit an additional risk 
for cognitive decline. We particularly wanted to examine the neurobiological 
signature of psychological risk in SCD.  
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3 Overview of Empirical Studies  
3.1 Study 1  
 
Performance of Spanish-speaking community-dwelling elders in the United States on the Uniform 
Data Set 
Benson, G., de Felipe, J., X. Luo & Sano, M. (2014). Alzheimer's & Dementia, 10(5), S338-S343. 
Theoretical background 
We investigated the effects of age, gender, and education on cognitive performance in a sample 
of cognitively intact Spanish speaking elders living in the United States (n=275). This work was 
motivated by the lack of descriptive of cognitive performance in this sample and was the first 
descriptive analysis of a multi-center neuropsychological test battery. The Uniform Data Set (UDS) is 
a standardized clinical and neuropsychological assessment for a multi-center research initiative of the 
National Alzheimer’s Coordinating Center (NACC). Importantly, as a minority group, there was very 
limited experience with the neuropsychological assessment of aging Spanish speakers living in the 
United States.  
We aimed to present cognitive performance on each cognitive measure described by age and 
education strata, thereby providing a measure against which to compare cognitive loss and dementia. 
Further, we wanted to investigate the effects of modifiable and non-modifiable risk factors on specific 
neuropsychological assessments. 
Hypothesis 
Given the descriptive nature of this study, it was primarily free of hypotheses. However, we 
expected demographic features to have the same effects on cognitive performance as reported in an 
English speaking sample (Weintraub et al., 2009). Namely, worsening of cognitive performance with 
increased age and better performances associated with increased levels of education.  
  
26 
Major Findings  
This work provided the initial cognitive data from clinically normal Spanish speakers in the 
UDS battery. Participants were notably younger and less educated compared to English-speakers 
recruited in the same sites. Consistent with previous literature, education and age played a significant 
role on neuropsychological measures; with higher education and lower ager associated with better 
performance.  
3.2 Study 2 
 
 Individual Correspondence of Amyloid-β and Intrinsic Connectivity in the Posterior Default Mode 
Network Across Stages of Alzheimer’s Disease 
Pasquini*

, L., Benson, G*., Grothe, M. J., Utz, L., Myers, N. E., Yakushev, I., ... & Sorg, C. 
(2017). Journal of Alzheimer's Disease, 58(3), 763-773.  
Theoretical background  
In AD, a striking overlap exists between the spatial distribution of Aβ pathology and the 
spatial distribution of functional connectivity. In particular, the aggregation of plaques has been 
associated with the DMN, a network composed by the medial prefrontal cortex, the medial temporal 
lobe and includes areas of the medial and lateral parietal cortices as the posterior cingulate and 
precuneus (Sorg et al., 2007; Sperling et al., 2009). Previous findings have led to the proposal of the 
network degeneration hypothesis (see section 1.3) which suggest that Aβ accumulation follows the 
DMN nodes, i.e. along functionally connected rather than spatially neighboring areas (Seeley et al., 
2009; Zhou et al., 2012). Previous work from Myers and colleagues reveled two distinct effects of Aβ 
on functional connectivity when assessing individuals with prodromal AD (Myers et al., 2014). At the 
global network level, the authors found positive correspondence, with plaque accumulating in areas of 
                                                          
 * Equal authorship contribution  
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 high connectivity; while at the local network they revealed a negative relationship, with Aβ 
plaque load negatively associated with connectivity. They found significant results across 
heteromodal networks, with the strongest results in the posterior DMN, which is a part of the DMN 
anchored in the posterior cingulate cortex (PCC).  
This study aimed to extend these findings and elucidate the intricate relationship between Aβ 
and network dysfunction across the temporal progression in the AD continuum in the DMN. Using a 
cross-sectional design involving multimodal imaging techniques, this study analyzed of a rich data 
sample (N= 90) including individuals in all stages across the AD continuum.  
Hypothesis 
The objective was to advance the understanding of neuropathological processes in AD and the 
relationship within functional connectivity in the DMN. Based on previous findings, we hypothesized 
a positive global and a negative local spatial correspondence starting at prodromal stages of AD and 
reaching a plateau at prodromal stages (MCI).  
Major Findings  
We revealed a positive spatial correlation between patterns of Aβ and functional connectivity 
across stages of AD, beginning in the preclinical stages. Showing that Aβ accumulates in areas of 
high connectivity and reaching a plateau at prodromal stages. Local correspondence was negative in 
network centers, indicating that Aβ reduces connectivity as a function of local Aβ accumulations, 
starting at preclinical stages and peaking when symptoms appear.  
3.3 Study 3 
 
Functional connectivity in cognitive control networks mitigates the impact of white matter lesions in 
the elderly. 
Benson, G., Hildebrandt, A., Lange, C., Schwarz, C., Köbe, T., Sommer, W., ... & Wirth, M. (2018). 
Alzheimer's research & therapy, 10(1), 109. 
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Theoretical background  
This study focuses on the resilience role of functional connectivity in the face of 
cerebrovascular pathology. WML are known to affect cognition in aging and is independently 
associated with an increased risk of dementia (Au et al., 2006; Debette & Markus, 2010; Raz & 
Rodrigue, 2006). The detrimental effect of WML on cognition has been shown to be attenuated by 
protective lifestyle factors, providing evidence for the CR hypothesis, which states that individuals 
with higher reserve are better able to cope with pathological insult (Brickman et al., 2011; Wirth et al., 
2014). It has been suggested that individuals with higher CR have brain activation patterns that reflect 
better neural efficiency, which may help maintain cognitive function in the face of pathology (Barulli 
& Stern, 2013). Recent works have proposed cognitive control networks, such as the fronto-parietal 
and the salience network, as neural correlates of CR (Franzmeier, Duering, Weiner, Dichgans, & 
Ewers, 2017; Serra et al., 2016).However , the neurobiological markers of these resilient mechanisms 
are unclear in the context of cerebrovascular pathology.  
 The present study aimed to investigate, whether resting state functional connectivity in 
cognitive control networks, as a proxy of CR, plays a mitigating role on the detrimental effect of 
WML on cognition. Functional connectivity was assessed using two approaches: a) global 
connectivity in the fronto-parietal network, the salience network, and DMN b) local connectivity 
within each network by extracting regions related to a cognitive reserve proxy (estimated based on 
education, premorbid IQ, and lifestyle behavior). Latent moderated structural educational modeling 
examined direct and interactive relationships between WML, functional connectivity and cognition in 
a sample of 230 non-demented participants.  
Hypothesis 
We hypothesized a detrimental effect of WML on cognitive functions both memory and 
executive function. We expected a moderating role of global and local functional connectivity in both 
the Fronto-parietal and the Salience network. Specifically, we expected that the negative effect of 
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WML on cognition would be reduced in individuals with higher levels of functional connectivity in 
both networks.  
Major Findings  
Increased WML load was associated with worse cognition, in both memory and executive 
function domains. Higher global functional connectivity in the fronto-parietal network and higher 
local connectivity between the salience network and the medial frontal cortex significantly attenuated 
the impact of WML on executive functions.  
3.4 Study 4 
 
Psychological risk associated with aberrant functional connectivity in subjective cognitive decline 
Benson,G., Schwarz, C. Sommer, W, Flöel, A. &Wirth, M. (In preparation). 
 
Theoretical background  
For this last project, we investigated the neurobiological underpinnings of psychological risk in 
older individuals with and without SCD. The presence of subjective cognitive decline (SCD) is 
associated with increased risk of AD (Jessen et al., 2014). Increase negative affect, such as anxiety, 
subclinical depression, rumination and neuroticism are associated with SCD, which in turn is a 
probable predictor of adverse brain alteration (Fredericks et al., 2018; Hill et al., 2016; Rabin et al., 
2015). Recent works have proposed an important role of negative affect in depleting resilience against 
brain pathology and accelerating cognitive decline in aging individuals (Marchant & Howard, 2015). 
Functional brain alterations have been demonstrated in SCD, with most studies focusing on the DMN 
alterations. However, few studies have examined the association of negative affect and functional 
connectivity in preclinical and prodromal AD. Increased negative affect has been related to functional 
brain alterations in MCI and early AD (Balthazar, 2013; Munro et al., 2015), and in a recent 
longitudinal study in healthy older adults, it was related to amyloid positivity and hyperconnectivity in 
the salience network (Fredericks et al., 2018). There is an essential need to further characterize the 
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unique psycho-affective profile of SCD and its neurophysiological underpinnings as it could lead to a 
better understanding of those individuals susceptible to decline.  
This study aims to investigate the association of psychological risk with behavioral measures 
(cognition, cognitive complaints, cognition, and psychological well-being) and functional brain 
mechanisms in a sample (N=101) of individuals with and without SCD.  
 Hypothesis 
We hypothesized the following: at the behavioral level presence and degree of SCD is related 
to negative affect, which itself is associated with worse cognitive performance and less psychological 
well-being. At the neurobiological level, negative affective is related with altered functional 
connectivity in both the DMN and the Salience Network, particularly in the SCD group. 
Major Findings  
Individuals with SCD reported higher negative affect, perseverative negative thinking, 
neuroticism and apathy than those without SCD. A higher degree of cognitive complaints was 
associated with greater negative affect and less psychological well-being, independently of SCD 
status. Our resting-state connectivity results indicate that negative affect was related to functional 
alterations in the DMN and Salience networks, in AD vulnerable brain regions and beyond, across our 
sample. Importantly, we showed a significant interaction effect of SCD and negative affect showing 
hyperconnectivity for those with higher negative affect in the SCD group in both networks.  
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4 Discussion  
 
In the following chapter I will discuss the major findings in light of our research questions and 
integrate them into the existing literature in the field. Lastly, I will present the limitations of the work 
and pointing out future research directions finalizing with a general conclusion.  
4.1 Summary and evaluation of major findings 
 
The relationships between pathology and resting state networks connectivity  
I investigated the intricate role of functional connectivity from resting state networks in the 
presence of pathology at different stages of the AD continuum and healthy older individuals. 
Specifically, study 2 investigated the temporal relationship of intrinsic functional connectivity and 
amyloid pathology across the AD continuum, while Study 3 investigated the protective role of 
functional connectivity in the presence of cerebrovascular pathology. Both these works shed light on 
the diverse mechanistic underpinning of functional brain networks, hinting at the complex interplay 
between the brain’s functionality at-rest and the multiple pathological processes.  
Complex trajectory of Aβ and functional connectivity correspondence affects Aβ accumulation and 
connectivity impairments starting at the preclinical stages.  
Our results from Study 2 add to a body of literature demonstrating relationships between Aβ 
burden and resting state functional connectivity (particularly, the DMN) (Buckley et al., 2017; 
Mormino et al., 2011; Sperling et al., 2009). In line with previous studies, we report a positive global 
correspondence between Aβ and intrinsic functional connectivity, indicating that Aβ preferentially 
aggregates in areas of high intrinsic connectivity, specifically the DMN (Myers et al., 2014). 
Critically, we expand these findings by demonstrating that this global correspondence starts in the 
preclinical stages in the absence of cognitive symptoms (cognitive intact individuals with Aβ 
pathology) and reaches a plateau as the disease progresses at the early MCI phase. Our examination of 
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correspondence between amyloid and functional connectivity at a local level revealed a negative 
relationship, particularly in the precuneous and posterior cingulate. Indicating that Aβ adversely 
affects (reduces) connectivity within the centers of the DMN as function of local plaque 
concentration. Across the continuum, the local deleterious effects of Aβ start at preclinical phases and 
peaked with the appearance of the first symptoms in early MCI remaining stable.  
Our results support the “network degeneration hypothesis” where intrinsic functional 
connectivity may determine amyloid accumulation patterns (Jones et al., 2016; Seeley et al., 2009; 
Zhou et al., 2012). Our negative local findings highlight the detrimental effects of Aβ on functional 
connectivity in network centers, starting at preclinical stages and peaking when symptoms appear. 
These findings suggest that wherever Aβ accumulation exceeds a certain threshold, accumulated 
pathology applies a stable long-lasting negative influence in local connectivity. This is in line with 
previous work, which report a mix of local network disruption due to Aβ in the network “hubs” 
(central nodes) in the DMN and other network including the Fronto-parietal, suggesting an overall 
pattern of regional vulnerability (Elman et al., 2016). Furthermore, these findings are in line with 
results from animal models of AD, which describe a deleterious action of amyloid-β pathology on 
activity of large-scale circuit function and local network organization (Busche et al., 2008; Palop & 
Mucke, 2010). Overall our findings shed light on the complex inter-relatedness of these mechanisms 
and highlight the brain changes that take place already in the preclinical stages of the disease.  
Investigating resilience: Functional connectivity from cognitive control networks attenuates the 
detrimental effects of cerebrovascular pathology 
We were interested on neurobiological basis of resilience mechanisms in resting-state network 
and investigated it in the context of cerebrovascular pathology. In study 3 we found that higher global 
functional connectivity in Fronto-parietal network and local connectivity between the salience 
network and medial frontal cortex significantly attenuated the impact of WML on executive functions. 
These findings suggest that higher connectivity in both cognitive control networks may protect against 
he detrimental effects of WML. These results are in line with previous findings from Franzmeier and 
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colleagues which support the protective role of Fronto-parietal network (Franzmeier et al., 2017a). 
Higher connectivity in this network has been associated with increased CR measures (IQ, education 
and occupation), and has been known to attenuate the effect of AD pathology on cognition in MCI 
and AD ( Franzmeier et al., 2017b; Franzmeier et al., 2017c). Previous report also support our local 
findings from the salience network, with similar brain regions (ACC to medial frontal cortex) 
correlating positively with higher education and preserved cognitive performance(Arenaza-Urquijo et 
al., 2013). Our finings extend the possible beneficial effects of functional connectivity against WML 
to include regions from the Fronto-parietal and the Salience network.  
The Fronto-parietal and the Salience network are considered crucial for regulation and healthy 
brain functioning. They support successful cognition, with increased functional hub connectivity 
linked to better performance(Liu et al., 2017; Menon, 2015). More efficient functional connectivity in 
these networks may facilitate adaptive connectivity patterns in the presence of neurodegeneration. The 
detection of resilience mechanisms may be suitable targets for therapeutic interventions to prevent 
additional cognitive decline. For example, cognitive enhancement techniques has been demonstrated 
by combining non-invasive brain stimulation over relevant brain areas (Antonenko, Hayek, Netzband, 
Grittner, & Flöel, 2019). Overall, our findings highlight the crucial role of functional connectivity 
from cognitive control networks as a neural correlate of resilience mechanisms in older individuals. 
Investigating Risk Factors in healthy older adults  
The influence and impact of modifiable and non-modifiable risk factors are not only important 
in the context of AD but also on cognition, mental health and the well-being in healthy aging. In study 
1 and 3, I investigated the effect of certain modifiable and non-modifiable risk factors on cognitive 
performance and the neurobiological signature of psychological risk in healthy older population.  
 Age and Education have an effect on cognitive performance in healthy older Spanish speakers 
living in the US  
Study 1 presents the performance on neuropsychological test battery from well-characterized 
cognitively intact older Hispanics living in the US. The limited experience with this cohort in research 
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has led to a gap in knowledge for the assessment of cognitive loss and dementia in this population. 
Our study provided the first assessment of the widely used UDS battery (Weintraub et al., 2009) for 
the Spanish-speaking cohort; and since its publication, it has been taken into consideration when 
assessing cognition in this population (Burke, Burgess, & Cadet, 2017; Porto, Russo, & Allegri, 2018; 
Ray, Sano, Wisnivesky, Wolf, & Federman, 2015). Consistent with the well-document phenomenon, 
we observed the detrimental effect of low education levels on cognitive performance across all tests 
(Hughes & Ganguli, 2009; Vemuri et al., 2012; Wilson et al., 2004). Contrary to our expectations, 
fewer test scores were affected by age, with younger age was associated with better performance in 
only three assessments (delayed recall, verbal fluency and executive function). Our results represent 
an important tool for assessing cognition and highlight the importance of taking education and age 
into consideration when assessing cognitive function in aging. These modifiable and non-modifiable 
risk factors are well known and studied in the field.  
Psychological risk: functional alterations in SCD  
A less studied phenomenon is the role and influence of psychological affective factors in the 
risk of cognitive decline and dementia. In my final study, we assessed psychological risk, measured 
through negative affect, and its association with functional brain mechanisms in cognitive normal 
individuals with and without SCD. As to be expected from the literature, individuals with SCD 
reported higher negative affect, which itself was associated with increased cognitive complaints and 
lower psychological well-being (Hill et al., 2017, 2016b). Across our entire sample, resting-state 
connectivity results indicated that negative affect was related to functional alterations in the DMN and 
SAL networks, in AD vulnerable brain regions (such as the precuneus) and beyond. Crucially, there 
was a significant interaction effect of SCD status and negative affect showing hyperconnectivity in 
the SCD group for those with higher negative affect in both networks. These results support the notion 
that psychological risk compromises brain functions, specifically in SCD, which reveal the 
importance of considering affective factors in early stages of subjective cognitive decline and aging.  
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It is important to note that connectivity changes presage the onset of objective cognitive 
impairments (Buckley et al., 2017). Thus, in the context of the initial “unspecified phase” of SCD, 
assessing the neurobiological basis of psychological risk might a lead to an identification of those 
individuals susceptible to further decline. In line with this train of thought, it is interesting that we 
only found a significant interaction of SCD status and negative affect at the neurobiological level. The 
functional connectivity alterations in the DMN and the Salience network are in line with previous 
findings that relate hyperconnectivity to higher affective symptoms in MCI, AD and individuals with 
positive amyloid biomarkers (Binette et al., 2018; Fredericks et al., 2018). Our study extends this in 
the concept of SCD and hints at distinct psychological profiles of SCD. It has been proposed that 
early relative hyperconnectivity may posit a detrimental effect as it may place neurons under 
metabolic stress, rendering them vulnerable to degeneration (Fornito, Zalesky, & Breakspear, 2015; 
Jones et al., 2015).  Therefore it is important to further study these connectivity alterations in these 
individuals as they age.  
4.2 Limitations and future perspective  
The importance of longitudinal design  
An important caveat to keep in mind in the interpretation of results is the cross-sectional nature 
of all four studies; hence no causal inference can be concluded. Few studies have examined risk and 
resilience factors more than a few years prior to the onset of objective decline and dementia; 
therefore, the discrimination between a true independent of a risk factor and a prodromal or early 
symptom becomes blurry. Life-long epidemiologic studies are needed in order to assess the 
interrelations and true associations of lifestyle factors on healthy and pathological aging (Hughes & 
Ganguli, 2009). Moreover, longitudinal neuroimaging and randomized controlled studies would help 
inform the progression and the synergies of the impact of lifestyle factors on brain structure and 
function. Specifically to our studies, longitudinal follow-up from our participants would allow to 
refine and confirm our proposed model of correspondence trajectory between Aβ and functional 
connectivity (Figure 3, Study 2). Regarding the protective role of functional connectivity, we could 
investigate the trajectories of the neuroprotective effects and examine whether there are non-linear 
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relationships with increase in cerebrovascular pathologies, as similarly proposed in study 2. Lastly, 
the longitudinal assessment of individuals with SCD is of most importance, not only for the early 
diagnosis of AD, but also for general healthy aging. The momentum in the research of risk and 
resilience factors is growing given the proposed evidence that we could modify the disease course, 
brain, and mental health by adapting lifestyle choices (Baumgart et al., 2015; Valenzuela et al., 2012).  
Sample, markers and proxies 
It is important to consider the limitations of a research sample setting. It is known that older 
participants, who are recruited through advertisements and pass screening criteria, tend to be well 
educated, resulting in a less heterogeneous sample. It is important to keep in mind such “celling 
effects” when assessing individual differences as it might compromise the accuracy of the estimation 
of the general population. Likewise, this posits a challenge in the study of resilient mechanisms as 
educational attainment plays a role has significant impact on AD biomarker trajectories. This effect 
has been particularly well-described by Vemuri and colleagues showing the different effects of 
intellectual enrichment on AD biomarkers and their interaction with genetic risk factors (Vemuri et 
al., 2016). Altogether this highlights the complex interaction between genetic and environmental 
factors, which is a major hurdle in the evaluation of behavior and assessment of the independent 
effects of each factor.  
Another challenge of empirically testing resilience is the abstract nature of the concept. Given 
that there is no direct golden standard measurement of reserve, most studies use different proxies, 
which can lead to a lack of common ground in interpretations. However, the field is moving in the 
right direction with recent attempts towards a homogenous and consensual integrations of the 
terminology, study-designs, and findings (Arenaza-Urquijo & Vemuri, 2018; Cabeza et al., 2018; 
Stern et al., 2018).  
Future research directions and outlook 
The field is moving and accepting the multifactorial nature of AD. The contributions and 
interactions from environmental, genetic, and several pathological processes are part of the holistic 
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models of the disease despite the challenges (design and analysis-wise) it presents. As specific 
markers of pathological process become more available, (i.e. tau pathology) and more inexpensive, it 
will be easier for the multimodal integration and investigation of risk and resilience mechanisms.  
 Future work should focus on the development of reliable and robust preclinical neuroimaging 
markers, with the inclusion of an optimal combination of several imaging modalities derived from 
retrospective and longitudinal studies. Future studies are also needed for the biopsychosocial approach 
to characterize individuals at the earliest phase of preclinical AD. The integration of psychological 
risk factors is needed in order to understand the etiological factors influencing the presentation, or 
lack there, of SCD. As the AD field pushes towards an earlier characterization of the disease, the 
understanding of trajectories of AD and the opportunities of targeted timely intervention becomes 
imperative.  
4.3 Conclusion  
The aim of this thesis was to elucidate risk and resilience mechanisms using a multimodal 
neuroimaging approach, while advancing the understanding of the intricate brain mechanisms during 
aging and AD. On the relationship between Aβ pathology and resting-state connectivity, we found a 
global positive correspondence and a local detrimental effect of Aβ on connectivity centers, starting at 
the preclinical phase. On the level of neurobiological resilient mechanisms, we demonstrated the 
protective role of cognitive control networks in the attenuation of the detrimental effects of 
cerebrovascular pathology on cognition. Lastly, we saw the direct effects of modifiable (education) 
and non-modifiable (age) risk factors on cognitive performance, and the neurobiological correlations 
of psychological risk on resting state connectivity in healthy older adults. We contextualized our 
findings within the holistic model of the AD, where interactions from environmental, genetic, and 
several pathological processes are taken into consideration in the course and severity of the disease.  
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ABSTRACT 
Background. Subjective cognitive decline (SCD) is consistently associated with negative affect, 
which, in turn, is a probable predictor of adverse brain alteration.  Negative affect may constitute a 
behavioral profile of psychological risk that potentially increase predisposition to AD. Aim: to 
investigate the association of psychological risk with behavioral measures and functional brain 
mechanisms in cognitively normal individuals with and without SCD. 
Methods Cognitively normal older adults with (n=51) and without (n=50) SCD underwent 
assessment of behavior, cognition, and functional magnetic resonance imaging. The relationships 
between psychological risk—measured through a combined score of negative affect—cognition, 
psychological well-being and functional connectivity were assessed. Functional connectivity was 
examined in two networks known to be vulnerable to AD, default mode network (DMN) and salience 
network (SAL), and tested for main effects and modification by SCD status using seed-to-voxel 
connectivity analysis.  
Results Presence and degree of SCD were significantly associated with increased negative affect, 
which, in turn, was related with lower psychological well-being. Greater negative affect correlated 
with functional connectivity alterations in the DMN (posterior cingulate cortex to middle frontal 
gyrus) and in the SAL (anterior cingulate cortex to precuneus) across both groups. Interactive effects 
show the precuneus and the post central gyrus to be associated with hyper-connectivity, specifically in 
SCD.  
Discussion Presence of SCD in older adults is associated with greater negative affect, which itself 
correlates with aberrant functional connectivity. Our findings suggest that psychological risk is a 
critical factor that compromises brain function in SCD and may be a suitable target for intervention in 
this early phase.   
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BACKGROUND 
Subjective cognitive decline (SCD) is commonly expressed in aging individuals in the absence of 
objective cognitive impairment. SCD is associated with increased risk for Alzheimer’s Disease (AD) 
and has been recently characterized as the earliest symptomatic stage of preclinical AD [1,2]. 
Accumulating evidence shows associations of SCD with increased biomarker abnormalities and AD 
pathology years before the onset of objective cognitive decline [3–6]. However, at this initial “phase”, 
SCD is an unspecific condition with multiple underlying etiologies, with some studies considering 
non-degenerative causes and overall poor health[7–9]. 
The presence of SCD is consistently associated with anxiety, subclinical depression, 
rumination, and neuroticism, a personality trait showing amplified reactivity to negative emotion [10–
12]. Importantly, these negative affects are related to increased risk for AD and are a probable 
predictor of brain alteration and cognitive decline [13–15]. The causal path from SCD to objective 
cognitive loss remains complex and multifaceted.  Recent works have proposed an important role of 
negative affect in depleting resilience against brain pathology and accelerating cognitive decline in 
aging individuals [16,17]. According to this concept, negative affect and maladaptive responses may 
constitute a behavioral profile of psychological risk that potentially increases the predisposition to 
develop AD. However, the characterization of negative affect and its association to functional brain 
changes in SCD remains unclear. 
Structural and functional brain alterations have been demonstrated in SCD [3,4,18], Previous 
studies have focused on connectivity alterations in the Default Mode Network (DMN), a network 
known to show first AD-related changes; with both increase [5] and decrease connectivity alterations 
reported in SCD [50]. However, few studies have focused on the association of negative affect 
symptomatology and functional connectivity in preclinical and prodromal AD. Reports show that 
stronger affective symptoms such as neuroticism, apathy and depression, are related to functional 
brain alterations in individuals with Mild Cognitive Impairment (MCI) and early AD [19,20]. In a 
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recent longitudinal study, Fredericks and colleagues [21] revealed that increased negative affect—
based on a composite of anxiety, depression, neuroticism, and vulnerability, named “emotional 
reactivity”—predicted amyloid positivity and was related to increased connectivity in the salience 
network (SAL) in cognitively normal individuals. There is an essential need to further characterize 
psychological risk in SCD and its neurophysiological underpinnings as it could lead to a better 
understanding of those individuals susceptible to further decline [16].  
 The present study aims to examine the psychological risk profile in SCD and its associations 
with behavioral measures and functional brain mechanisms. First, we assess relationships between 
psychological risk (measured through a combined score of negative affects) and objective cognition, 
cognitive complaints, as well as psychological well-being in older individuals with and without SCD. 
Second, we examine the association between psychological risk and functional connectivity in two 
resting state networks, the DMN, and the SAL network. We hypothesized the following: At the 
behavioral level presence and degree of SCD are related to negative affect, which itself is related to 
lower cognitive performance and less psychological well-being. At the neurophysiological level, 
negative affect is related to altered functional connectivity in both resting-state networks, particularly 
in the SCD group.  
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METHODS 
Participants  
Data used in this study were obtained from the ongoing SmartAge trial (ClinicalTrials.gov: 
NCT03094546) data release (01.06.2018) [22]. At the time of analysis, data from 101 participants, n = 
51 individuals with SCD and n=50 without SCD (SCD-), were available. Cognitively normal 
individuals (60-90 years old) were recruited through health care facilities and advertisements in the 
general population. SCD was diagnosed using established guidelines [1] that included presence of 
subjective cognitive complaints for at least 6 months, self-reported associated worries and 
endorsement to seek medical help due to these concerns. Participants without SCD (SCD-) were 
included if they denied any subjective cognitive worsening or if such cognitive worsening was 
considered of no concern. For all participants, screening criteria for normal cognitive performance 
was measured using the Mini Mental State Examination (MMSE) [23] (score ≥ 26), the logical 
memory subscale total delayed recall [24] and the trail making test A [25] (both scores >-1.5 standard 
deviation [SD] of age adjusted norms). Exclusion criteria for both groups included deficits in 
activities of daily living [26] and a Geriatric Depression Scale (GDS) [27]score > 10, as well as severe 
medical, neurological or psychiatric disease.  
All participants underwent assessment of behavior, cognition, and functional magnetic 
resonance imaging, further details of the study are provided elsewhere [22]. Family History of AD 
and non-specified dementia was defined within the first-degree family members. Overall, six subjects 
were excluded from imaging analysis due to incomplete visit (n=1), missing MRI data (n=4), failed 
quality control procedures (n=1), with the remaining 96 subjects comprising the final sample for 
imaging analysis (49 SCD, 47 SCD-). The study was approved by the ethics committee of the Charité 
University Medicine Berlin Germany, and was in accordance with the declaration of Helsinki. All 
participants provided informed written consent.  
Neuropsychological Testing  
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A battery of neuropsychological tests was administered to all the participants to assess 
cognitive performance. A global cognitive measure was derived similar to the Preclinical Alzheimer’s 
Cognitive composite (PACC 4).  This measure was designed to provide distinctive information about 
early cognitive decline in cognitive intact individuals [28]. Test scores were z-transformed and 
averaged to create composite scores from the following test: Total MMSE score [23] , total immediate 
learning recall from the German version of the Auditory Verbal Learning Test (VLMT) [29], the 
logical memory total delayed recall [24] and the Digit Symbol substitution test.  
Self-reported behavioral measures 
Self-reported questionnaires were administered on site and at home. Psycho-affective 
measures were selected from the questionnaire battery [22]. Depressive affect was assessed through 
the Geriatric Depression Scale (GDS) short version (15 items) [30]. Rumination was assessed with the 
23-item Response Style Questionnaire (RSQ-D), which quantifies the extent to which individuals 
respond to negative events by focusing on self, symptoms, and distraction [31]. Neuroticism, a 
personality trait, was assessed using the Big-Five Inventory  (BFI) neuroticism score from the10-item 
questionnaire [32]. Stress Coping was evaluated with the 78-item Stress Coping Style Questionnaire 
(SVF-78), which assesses the coping style (positive or negative) of an individual’s particular way of 
reacting to stressful situations [33].  
Further, we selected the following behavioral measures: The degree of Cognitive complaints 
was assessed with the 39-item Everyday Cognition Scale (ECOG) with the average score provided by 
the total amount of answered questions as reported in the established scoring method [34]. 
Psychological well-being was assessed using the WHO Quality of Life-BREF (WHOQOL-BREF) 
psychological well-being subscale [35].  
Assessment of psychological risk 
Motivated by the conceptual relevance proposed by Marchant and Howard [16],  we calculated a 
negative affect composite from the psycho-affective measures selected to best represent the 
individual’s psychological risk. We conducted exploratory factor analysis using a principal 
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component analysis (PCA) estimation approach and a varimax rotation [36],  to explore the 
relationship among all the psycho-affective measures (Table 1), similar to previous approaches 
[19,37,38]. The Kaiser–Meyer–Olkin (KMO) measure verified the sampling adequacy for the 
analysis, KMO=0.70, and Bartlett's test of sphericity X2 (28)=253.411, P<0.01, indicated that 
correlations between items were sufficiently large for PCA. Two components had eigenvalues over 
Kaiser's criterion of 1 and in combination these two factors explained 59.8% of the variance. Table 1 
shows the factor loadings after rotation.  The first PCA (PC1) was composed of negative coping, 
neuroticism, GDS, symptom- and self-rumination, and suggests that this component represents 
negative affect while the second component (PC2) contrasted more positive coping strategies. Given 
the aim of the study, the resulting factor score from PC1, thereafter referred to as negative affect 
score, was extracted and used for further analysis with higher scores indicating higher negative affect. 
 
Table 1. Summary of principal component analysis to extract Negative Affect scores for the entire 
sample 
 
Measures Rotated factor loadings  
  Negative Affect Positive Coping 
Symptom Rumination 0.88 0.073 
Self Rumination 0.76 0.35 
Neuroticism 0.62 −0.50 
Negative Coping 0.831 −0.13 
Geriatric Depression Score 0.63 −0.37 
Distraction Rum 0.10 0.84 
Positive Coping -0.11 0.82 
Note: factor loadings pertaining to a factor appear in bold.  
 
MRI acquisition  
Scans were acquired using a 3 Tesla Magnetom Trio (Tim Trio; Siemens AG, Erlangen, 
Germany) at the Berlin Center for Advance Neuroimaging (BCAN). T1-weighted images were 
acquired with magnetization-prepared rapid acquisition gradient-echo (MPRAGE) with the following 
parameters, repetition time (TR = 1900 ms; TE = 2.52 ms; 192 sagittal slices; size = 1.0×1.0×1.0 
mm
3
; flip angle = 9°). Functional scans were obtained at rest using T2*-weighted EPI sequence (TR = 
2300 ms; TE = 30 ms; 34 slices; size = 3.0×3.0×4.0 mm
3
; flip angle = 90°). During the  7-min resting-
state scan participants were instructed to keep their eyes closed and not think of anything in particular. 
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Preprocessing and analysis of resting state functional MRI  
The publicly available CONN Functional Connectivity Toolbox version 17C 
(www.nitrc.org/projects/conn), in conjunction with SPM 12 (Wellcome Department of Cognitive 
Neurology, London, UK; www.fil.ion.ucl.ac.uk/spm) was used to perform all preprocessing steps 
[39]. In detail, we used the default pre-processing pipeline: raw functional images were slice-time 
corrected, realigned (motion corrected), and co-registered to each participant’s MPRAGE image. 
Images were then normalized to Montreal Neurological Institute (MNI) standard space and spatially 
smoothed with an 8-mm Gaussian filter. Identification of outlier scans was performed using Artifact 
Detection Tools (http://www.nitrc.org/projects/artifact_detect) [39]. Specifically, it regresses out 
scans as nuisance covariates in the first-level analysis exceeding 3 SD in mean global intensity and 
frame-to-frame difference exceeding 0.5 mm (combination of translational and rotational 
displacements).  
Resting state images were band-pass filtered (0.008-0.09 Hz) and corrected with the 
implemented component correction (CompCor) strategy [40], including the removal of white/ 
cerebrospinal fluid time series, motion and artifact-outlier regressors, to reduce the influence of blood-
oxygen level dependent (BOLD) signal unrelated to neural activity. There were no significant 
differences between the two groups in the number of outlier scans (p=0.84) or mean motion (p=0.82).  
Functional connectivity assessment  
 Functional connectivity was assessed in both the DMN and SAL networks. Individual 
connectivity maps were derived using seed-to-voxel analyses from CONN. First level whole brain 
correlational maps were generated by extracting the mean resting state BOLD time course for each 
seed and calculating the Fisher-transformed correlation coefficients with the BOLD time course 
throughout the whole brain. For each network the following seeds were used: the posterior cingulate 
cortex (PCC): 1,-61,88 for the DMN and the anterior cingulate cortex (ACC): 0,22,35 for the SAL. As 
defined in our previous work [41],  we chose these seeds, given that they are characterized as core 
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network hubs[42,43]. Individual connectivity maps were then subjected to voxel-wise second-level 
analysis. 
Statistical methods 
Statistical analyses were performed with SPSS software 24.0 (PASW, SPSS; IBM, Armonk, NY) and 
R  (version 3.5.0) [44]. A two-sided significance level of α=0.05 was used. Differences between 
groups (SCD, SCD-) were first assessed on selected demographic, behavioral measures, psycho 
affective measures, as well as cognitive measures using t-test for continuous variables and Fisher’s 
exact test for categorical variables. 
Next, we examined associations between negative affect score, group status, and behavioral measures. 
Separate multiple linear regression analyses were conducted to investigate relationships between 
negative affect (predictor) and cognitive complaints, cognitive performance, as well as psychological 
well-being (outcome variables) in the total sample. In a second step, these statistical models were 
adjusted for group status and age. In order to further investigate whether there was a modification of 
these relationships by SDC status, the interactive term (SCD status × negative affect sore) was added 
in a third step. 
Associations between negative affect and resting-state functional connectivity in the pre-selected 
resting state networks (DMN and SAL) were conducted using voxel-wise second-level analyses. First, 
we assessed the main effect of negative affect (predictor) on functional connectivity within these 
networks in the total sample, as previously done [41,45]. In a second step, these models were adjusted 
for group status and age.  Next, the interaction effect between negative affect and SCD status was 
conducted at the voxel-wise level to assess group differences. This was done, by adding the 
interactive term (SCD status × negative affect sore) in a third step as a predictor in the one-way 
ANCOVA models [39]. Significance threshold was established at p< 0.05 false discovery rate (FDR) 
level-correction for multiple comparison and a voxel-level threshold of p < 0.005 [39]. Average 
individual functional connectivity values were extracted from the significant regions as Z-scores. This 
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connectivity measure was plotted for visualization and interpretation of the directionality using the R 
package Jtool (available at : https://cran.r-project.org/web/packages/jtools/). 
 
RESULTS  
Demographic 
Details of the demographic data are shown in table 1. Participants in both groups did not 
differ in terms of age, education, sex ratio or cognitive performance. Individuals with SCD reported a 
higher family history of AD and Dementia and reported higher cognitive complaints than those 
without SCD.  
Importantly, the SCD group significantly differed in 6 of the 9 psycho-affective variables 
from the SCD- group, that indicate a presence of negative affect (Table 2). Correspondingly, 
individuals with SCD had a significantly higher negative affect score (combined measure), when 
compared to SCD-. 
 SCD- SCD p 
Demographics 
   
N (n Women) 50 (25) 51 (25) .24 
Age (years) 71 (6), 60-85 70 (6),60- 83 .66 
Education  16.4 (3.4), 10- 29 16.5 (3.6) 11- 27 .80 
Family History of Dementia (%)  14%  54.9% .01 
Cognitive Complaints    
 Every Day Cognition Overall  1.3 (.3) 1.0-2.4 1.8 (.5), 1.1-3.6 .00 
 Every Day Cognition Memory 1.5 (.4), 1.0-2.7 2.3 (.6), 1.3-4.0  .00 
Psychological Well-Being  
77.8 (12.1) 45-100 70.3 (11.8) 37.5-95.8 .00 
Cognition    
Global Cognition: PACC4 .11 (.63) -1.3- 1.5 -.10 (.72) -2.2- 1.34 .12 
Psycho-affective Measures    
Geriatric Depression Scale  0.8 (.8), 0-3 1.9 (1.7), 0-6 .00 
RSQ-Self Rumination 10.6 (2.8), 7-19 11.9 (3.1), 7-18 .03 
RSQ-Symptom Rumination 11.4  (3.0), 8-20 13.7 (3.9), 8-24 .00 
RSQ- Distraction  18.9 (5.4), 8-28 19.8 (4.2), 9-32 .36 
Stress Coping Positive 13.1 (2.4), 6.6-21.1 13.2 (2.4), 6.9-18 .48 
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Stress Coping Negative 8.3 (3.3), 0.8-16.8 10.1 (4.4), 2.3-21 .02 
Personality Neuroticism 2.6 (.9) 1.0-5.0 3.1 (1.0) 1-5 .02 
Negative Affect Score (combined) -.35 (.75) -1.8- 1.9 .34 (1.9) -1.7- 2.7 .00 
Table 1. Demographics and characteristics, numbers are expressed as mean (standard 
deviations) and range. Independent sample t-test for continuous variables and chi-square test for 
categorical, Bonferroni corrected. Key: PACC4 Preclincal Alzheimer’s Cognitive Composite  
Relationships between negative affect and behavioral measures  
Greater negative affect score was associated with more cognitive complaints (b=.27; SE= .03 p>. 01 ; 
CI =.20-.35) and less psychological well-being ( b=-8.56; SE =.91; p<.01, CI =-10.38 -6.76) in the 
total sample. Negative affect was not associated with cognitive performance (b = -.04; SE= .07; 
p=.57, ; CI= -.16 .09), and remained after adjusting for age and group. Also, the SCD status had no 
significant effect on these associations, as none of the interactions (SCD status × negative affect) were 
significant (p>.05) for either cognitive complaints (F(1,98)= .02;  p=.96) , psychological well-being 
(F= (1,98)=1.69 ; p=.20), nor cognition (F(1,98)=.08 p=.89). 
Relationships between negative affect and functional connectivity 
 Results of the main effect seed-to-voxel analyses across the entire sample (n=96) are shown in Figure 
1 and Table 2.  In the DMN, a higher negative affect score was significantly related to higher 
connectivity between the PCC and the middle frontal gyrus. In the SAL, a higher negative affect score 
was associated with lower connectivity between the ACC and the precuneus and the precentral gyrus. 
These results remained significant after controlling for SCD status and age. Cluster information is 
presented in Table 2. 
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Figure 1. Main effect of negative affect on functional connectivity across all participants. In 
the DMN (A), higher negative affect was related to higher connectivity between the PCC and in the 
middle frontal gyrus (MidFG). In the SAL (right side), higher negative affect was related to lower 
connectivity between the ACC and the precuneus (PCU) as well as the precentral gyrus (p<.005 ; 
FDR Corrected).  The scatterplot illustrates the relationship, negative affect plotted over individual 
functional connectivity that was extracted from the significant cluster, Pearson’s correlation 
coefficient, p<.05 displayed in each graph.   
Results of the interaction effect seed-to-voxel analyses are shown in figure 2. In the DMN, brain 
regions showing a significant interactive effect (SCD status × negative affect) included post central 
gyrus and the Precuneus for the SAL. In both regions higher negative affect was related to increased 
functional connectivity for the SCD group, and lower functional connectivity in the SCD- group. 
These results remained unchanged after controlling for age. 
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 Figure 2. Brain regions showing an interactive effect of SCD status by functional 
connectivity on negative affect score in the DMN and SAL networks. Brain regions included (A) the 
cingulate gyrus/precuneus (PCUN) for the DMN and (B) the left postcentral gyrus (PostCG) for the 
SAL (p<.005 FDR Corrected). In both regions higher negative affect score was related to increased 
connectivity for the SCD group and lower connectivity for the SCD-.  Representations of the 
interaction effects were illustrated with regression line on scatterplots. Shaded area indicates 95% 
confidence intervals; p values of the interaction are displayed for each graph.  
Regions # Voxel p-corrected T Peak MNI Coordinates ( x, y 
z) 
Default Mode Network seed: PCC 
Middle Frontal Gyrus left 200 .023 4.68 -36 +04 +46 
Salience Network  seed: ACC 
Precuneus 188 .042 -4.75 +06 -44 +44 
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Inferior Temporal Gyrus 
Posterior division left  
164 .042 -4.15   -56 -44 -22 
Voxel Wise-Interaction Results      
Default Mode Network seed: PCC      
Cingulate Gyrus/ Precuneus 
cortex 
134 0.02 3.91  +04 -46 +20 
Salience Network  seed: ACC      
Postcentral gyrus left / 
Heschls Gyrus Left 
181 .019 4.61  -44 -22 +12 
Table 2.  Coordinates of the local maxima peaks that showed a significant main effect and 
interactive effect of negative affect.  Significant Cluster at p<0.005 FDR corrected p<.05 
  
  
67 
DISCUSSION  
The present study evaluated psychological risk, measured through negative affect, and its 
association with functional brain mechanisms in cognitively normal individuals with and without 
SCD. As to be expected from the literature, individuals with SCD reported higher negative affect, 
perseverative negative thinking, neuroticism and apathy than those without SCD. Overall, negative 
affect was associated with increased cognitive complaints and lower psychological well-being, 
independently of SCD status. Across our sample, resting-state connectivity results indicate that 
negative affect was related to functional alterations in the DMN and SAL networks, for example in 
the precuneus—an AD vulnerable brain region—and beyond. Importantly, there was a significant 
interaction effect of SCD and negative affect showing hyperconnectivity in the SCD group for those 
with higher negative affect in both networks. Our results support the notion that psychological risk 
compromises brain functions, specifically in SCD, which reveal the importance of considering 
affective factors in early stages of cognitive decline and aging.   
Our results are consistent with previous findings which show that presence of SCD and the 
degree of cognitive complaints are associated with increased negative affect and personality factors 
such as neuroticism, in the absence of objective cognitive impairment [7,9,12]. In addition, our results 
highlight rumination as part of the psycho-affective characteristics that help form the profile of 
SCD[46], an important construct of maladaptive reaction to life situations, which should be further 
studied in SCD[16]. As expected, psychological well-being and cognitive complaints were related to 
negative affect. The nature of this relationship is in line with previous findings, showing affective 
symptoms co-occurring in the presence of cognitive complaints; and overall quality of life, 
particularly psychological well-being, associated with degree of cognitive complaints in older 
adults[47]. Contrary to our expectation, no associations were found between negative affect and 
cognitive performance. Although increased psycho-affective symptomology is related to risk for 
cognitive decline, this association might not be present at this asymptomatic stage. Longitudinal 
studies might be needed to witness these associations in SCD.  
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 We found that greater psychological risk, as measured through higher negative affect, 
correlated with functional connectivity alteration in the DMN (posterior cingulate cortex to middle 
frontal gyrus) and in the SAL (anterior cingulate cortex to precuneus) in our entire sample, a 
relationship that was independent of age and SCD status.  Importantly, these functional associations 
are seen in AD- vulnerable regions such as the precuneus (a hub normally comprising the DMN), 
which is related to socio-affective and self-referential thinking[48,49]. Previous studies have focused 
on connectivity alterations in the DMN, a network known to show first AD-related changes and to be 
involved in introspection; with both increase [5] and decrease connectivity alterations reported in 
SCD [50]. Conversely, alteration in the SAL, a system critical for social processing, have been 
reported across the AD spectrum[51], with connectivity changes related to emotional reactivity in 
cognitively normal elders [21]. Interestingly, similar alterations in functional connectivity in both the 
DMN and SAL, extend to other neuropsychiatric disorders such as major depression[52] and 
obsessive-compulsive disorder[53], suggesting neural circuitry abnormalities implicated in the 
processing of affective input and emotion internalization [54].  
 In the present study, we found an interactive effect of psychological risk and SCD status, 
showing regional hyperconnectivity for the SCD group with increased negative affect in both the 
precuneus and post-central gyrus (Fig. 2). These results are in line with previous evidence of regional 
hyperconnectivity associated to increase emotional reactivity [21] and increased neuropsychiatric 
factors [55] in cognitively normal older adults at risk for AD.  Our findings extend this evidence in the 
context of SCD and hints at a distinct psychological profile of SCD, which exhibits a differential 
neurobiological correlate, namely, increased relative connectivity. It has been proposed that early 
relative hyperconnectivity may posit a detrimental effect, as persistent hyperconnectivity in some 
regions may place neurons under metabolic stress, rendering them vulnerable to degeneration [56,57]. 
However further longitudinal studies that incorporate psycho-affective measures and biomarkers are 
needed to inform whether, and to what extent, does psychological risk predicts conversion to 
dementia in SCD.  
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Coupled with previous works, our current findings elucidate the association of negative affect 
and functional brain alterations in SCD. Affective factors are important to examine in the context of 
SCD given its association with increased risk for AD preceding cognitive decline [14]. Psycho-
affective symptoms become more frequent in early or preclinical stages of cognitive dysfunction [58] 
and are related to differential patterns of AD biomarkers [12]. Therefore identifying mechanism 
serving psychological risk may help characterize those most susceptible to further decline. Further 
understanding the distinct profiles of SCD might help identify those who may respond to different 
interventions (i.e. cognitive behavior therapy) and possibly prevent overall decline.  
The interplay of SCD and affective symptoms in the earliest preclinical stages of AD remain 
complex. Possibly the internalization of the experience of cognitive decline might play an important 
role in the trajectory of decline. For example, self-experience of cognitive deterioration can precipitate 
worry about AD, increasing the negative affective symptoms, which in turns exacerbates or 
accelerates SCD and the overall vulnerability towards AD.  Contrarily, certain psycho-affective 
profiles might just be more sensible to the subtle experience of cognitive decline while already on the 
path of pathological degeneration course. Although these causal trajectories are beyond the scope of 
this study, it nevertheless highlights the need for further clarification and supporting evidence.   
There are some important limitations to consider. First, our study is somewhat limited by its 
cross-sectional approach. Further longitudinal studies are needed to capture the value and trajectory of 
connectivity alterations as subjective decline becomes objective. Second, our measure of 
psychological risk is a construct derived from our sample and needs further validation. The study of 
psycho-affective measures as risk factors is heterogeneous in the field, with similar proxies  (i.e. 
“neuropsychiatric burden”,  “affective symptoms”) converging comparable results [10]. Some might 
argue that certain negative affect, like depression, should be treated as confounding factors, however 
the guidelines of the field of SCD the field suggest against as it provides an incomplete understanding 
of the expression of SCD[1,2,59]. Lastly, our functional connectivity findings are limited to two 
networks and should be explored by other functional connectivity measures such as inter-network, 
degree centrality and other brain networks.  
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Conclusion 
Presence of SCD in older adults is associated with greater psychological risk, which itself 
correlates with aberrant functional connectivity in AD vulnerable brain regions and beyond. Our 
findings suggest that psychological risk may compromise brain health and potentiate its adverse 
impact in SCD. The factor needs to be considered, when investigating suitable intervention strategies 
in this group. 
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Supplement 
 
 
Table 1. Effects of Negative Affect on Cognitive Performance, Cognitive Complaints and 
Psychological Well-being  
 B SE  β R
2
 95 % P 
Negative Affect 
Cognition -.04 .07 -.06 .04 -.18, .09 .52 
Cognitive Complaints .27 .03 .61 .37 .21,.35 <.01 
Psychological Well Being -8.56 .91 -.69 .47 -10.3, -6.7 <.01 
Associations of Negative Affect  (n=100) on Cognition, Cognitive complaints, Psychological Well-being reported 
as individuals simple linear regressions . Negative B values indicate worsening in cognitive performance  and psychological 
well-being  
 
 
 
 
 
 
